Coronavirus Update – Impact on Valuing Private Investments at December 31, 2020

This has been a challenging year for all. The medium- and long-term economic impact of the pandemic remains to be seen. Volatile public markets have, to some extent, muted the potential impact on the fair value of private investments in the short-term. With a resurgence of the spread of the COVID-19 on one hand and news of potential effective vaccines on the other hand, there remains risk and uncertainty that will impact year-end valuations.

As a follow-up to our earlier webinars, we will discuss key concerns and suggestions for estimating fair value at December 31, 2020. Our experts will answer questions and discuss practical steps fund managers and investors in non-traded or infrequently traded equity, debt and structured product investments can take as they exercise their fiduciary duty to report independent and credible fair value information to investors and stakeholders.

Schedule: 12:00 p.m. – 1:15 p.m. EST

Topics

• What future economic view should be reflected when valuing illiquid investments at December 31, 2020?
• Public markets remain volatile but have rebounded to near historic highs. Does this mean that the valuation of private investments should also be at historic highs?
• What view would be expected from portfolio companies as they project future cash flows?
• How should the fair value of various investment types, including early stage (VC), structured products, real estate, private debt, private equity, LP interests and energy-related, be determined at December 31, 2020?

Speakers

• David Larsen, Managing Director, Portfolio Valuation, U.S.
• Ross Hostetter, Managing Director, Portfolio Valuation, U.S.
• Ryan McNelley, Managing Director, Portfolio Valuation, EMEA
• David Scott, Managing Director and Co-Leader Energy & Mining, Portfolio Valuation, U.S.
• Ross Prindle, Managing Director and Global Head of the Real Estate Advisory Group
• Jennifer Press, Managing Director, Financial Instruments and Technology, U.S.